Skip to main content
Equibles

CLLS · Cellectis S.A.

Track CLLS — free

Use CLLS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CLLS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.41 -0.02 (-1.40%)
Rebalance outlook locked
Market Cap
$151.08M
Shares
100.72M
Volume · Oct 5 37.26K Avg daily vol (3M) 76.81K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.43 Open$1.45 Day$1.42–1.47 52W close$1.38–5.35 Avg vol 30d144K Short int488K · 0.5% float · 2.4d Short vol29% Last earningsAug 6, 2026 DataJan 2020–Oct 2026

Up next

Next earnings call
Jan 13, 2027 Est · unconfirmed · in 14 wks
Q2 2025 earnings call transcript
call held Jun 30, 2025

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
+107.5%
Year over year
Operating margin
-45.3%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+57.1%
Year over year · more shares
Price change (1Y)
-58.2%
Trailing year
Short interest
0.5%
Latest settlement · 2.4 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Bearish Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 15.3 · calm Equity put/call 0.58
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −58%
below
Price vs 50-day avg −45%
below
RSI (14) 27
oversold
MACD trend Negative
52-week position 1%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −57%
trailing
6-month return −67%
trailing
YTD return −70%
this year
Relative strength −79%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $3 › 200d $3 — 200d above 50d
Institutional flow Distributing
-16% holders QoQ · +3 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.48% of float · ▲ +68.5% MoM · 2.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
27 holders — mid 3-yr range
Squeeze score 45
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 85%
annualized · 1-yr
Max drawdown −74%
past year
ATR 11.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−58% Bearish
Price vs 50-day avg
−45% Bearish
RSI (14)
27 Neutral
MACD trend
Negative Bearish
52-week position
1% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $3 › 200d $3 — 200d above 50d
Institutional flow Distributing
-16% holders QoQ · +3 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.48% of float · ▲ +68.5% MoM · 2.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
27 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $1 Now $1 · 1% Range high $5
vs 200-day avg -58% vs 50-day avg -45%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
CLLS
Cellectis S.A.
this stock
$151.08M -70.5% — — 0.5%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $133.37B +11.3% +46.2% 30.7 1.9%
REGN
Regeneron Pharmaceuticals, Inc.
 $81.13B -4.8% +20.8% 19.5 2.5%
MRNA
Moderna, Inc.
 $79.40B +544.3% +4.3% — 8.2%
CSLLY
Csl Ltd
 $61.25B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
27
% held
9.4%
Net QoQ
-767.5K sh
Top holder
B Group, Inc.
Held Float
View
Held by Funds
Fund positions
5
View
Short & Settlement
Short Interest Rising
Shares short
488.1K
Days to cover
2.4d
Change
+198.4K sh
View
Short Volume
Short vol %
29%
As of
Oct 2, 2026
Short Total
View
Fails to Deliver
FTD shares
11.0K
Value
$34.2K
As of
Sep 14, 2026
View
Off-Exchange
Off-exchange %
58.1%
Week of
Aug 31, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
6-K
Filed
Sep 14, 2026
This year
27
View
Earnings & Events
Webcasts Upcoming
Next webcast
Nov 10, 2026
Last webcast
Sep 15, 2026
View
Investor Relations
Upcoming events
4
View

Performance

5D 20D 120D MTD YTD
CLLS -2.7% -56.9% -66.6% -5.3% -70.5%
SPY -0.2% -0.5% +12.2% +0.9% +12.9%
vs SPY -2.5% -56.5% -78.8% -6.2% -83.3%
Key facts CIK 1627281 CUSIP 15117K103 Visit website Investor relations